www.globaldata.com Open in urlscan Pro
52.31.121.136  Public Scan

Form analysis
4 forms found in the DOM

<form novalidate="">
  <fieldset class="price_sec">
    <div class="subscription-level">
      <div class="form-radio ">
        <input id="radio_subscription-single" name="radio_subscription-level" value="1958506" type="radio">
        <label for="radio_subscription-single">Single User</label>
      </div>
      <span data-tooltip="" title="" aria-describedby="mz0teh-tooltip" data-yeti-box="mz0teh-tooltip" data-toggle="mz0teh-tooltip" data-resize="mz0teh-tooltip" class="has-tip" data-e="fvfwuc-e"><i class="gd-ico gd-info"></i></span>
      <!-- <div class="price"><span>$3,995</span><span class="discount">$3,995</span><span class="discount-off">(20% off)</span></div> -->
      <div class="price"><span class="woocommerce-Price-amount"><span class="woocommerce-Price-amount amount"><bdi><span class="woocommerce-Price-currencySymbol">$</span>1,950</bdi></span></span> <span data-price="500000"
          class="js-hide local-price js-local-price" style="display: none;"></span></div>
    </div>
    <p>Can be used by individual purchaser only</p>
  </fieldset>
  <fieldset class="popular price_sec">
    <legend>Most Popular</legend>
    <div class="subscription-level">
      <div class="form-radio ">
        <input id="radio_subscription-multi" name="radio_subscription-level" value="1958507" type="radio" checked="">
        <label for="radio_subscription-multi">Multi-users</label>
      </div>
      <span data-tooltip="" title="" aria-describedby="jsb4vl-tooltip" data-yeti-box="jsb4vl-tooltip" data-toggle="jsb4vl-tooltip" data-resize="jsb4vl-tooltip" class="has-tip" data-e="cx7dxn-e"><i class="gd-ico gd-info"></i></span>
      <div class="price"><span class="woocommerce-Price-amount"><span class="woocommerce-Price-amount amount"><bdi><span class="woocommerce-Price-currencySymbol">$</span>2,925</bdi></span></span> <span data-price="500000"
          class="js-hide local-price js-local-price" style="display: none;"></span></div>
      <!-- <div class="price"><span>7,990</span><span class="discount">7,990</span><span class="discount-off">(20% off)</span></div> -->
    </div>
    <p>Can be shared by unlimited users within one corporate location e.g. a regional office</p>
  </fieldset>
  <fieldset class="price_sec">
    <div class="subscription-level">
      <div class="form-radio ">
        <input id="radio_subscription-enterprise" name="radio_subscription-level" value="1958505" type="radio">
        <label for="radio_subscription-enterprise">Enterprise</label>
      </div>
      <span data-tooltip="" title="" aria-describedby="fzikdm-tooltip" data-yeti-box="fzikdm-tooltip" data-toggle="fzikdm-tooltip" data-resize="fzikdm-tooltip" class="has-tip" data-e="2avzem-e"><i class="gd-ico gd-info"></i></span>
      <div class="price"><span class="woocommerce-Price-amount"><span class="woocommerce-Price-amount amount"><bdi><span class="woocommerce-Price-currencySymbol">$</span>3,900</bdi></span></span> <span data-price="500000"
          class="js-hide local-price js-local-price" style="display: none;"></span></div>
      <!-- <div class="price"><span>$11,985</span><span class="discount">$11,985</span><span class="discount-off">(20% off)</span></div> -->
    </div>
    <p>Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company</p>
  </fieldset>
</form>

<form class="gs3k"><textarea placeholder="Write a message…" spellcheck="true" rows="1" enterkeyhint="send" class="gs20 gs3l" style="height: 0px;"></textarea><input type="file" multiple="" class="gs3j"><button class="gs21 gs21_1 gs3m gs3p gs3n"><svg
      width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg">
      <rect width="16" height="16" fill="none"></rect>
      <path fill-rule="evenodd" clip-rule="evenodd"
        d="M8 3C7.44772 3 7 3.44772 7 4V7L4 7C3.44772 7 3 7.44771 3 8C3 8.55228 3.44772 9 4 9H7V12C7 12.5523 7.44772 13 8 13C8.55228 13 9 12.5523 9 12V9H12C12.5523 9 13 8.55228 13 8C13 7.44772 12.5523 7 12 7L9 7V4C9 3.44772 8.55228 3 8 3Z"
        fill="black" class="gsac"></path>
    </svg></button><button class="gs21 gs21_2 gs3m gs3q"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg">
      <path fill-rule="evenodd" clip-rule="evenodd"
        d="M8.63965 3.53354C8.2688 3.2245 7.73013 3.2245 7.35928 3.53354L4.12133 6.23183C3.40282 6.83059 3.82622 8 4.76151 8H7V12C7 12.5523 7.44718 13 8 13C8.55175 13 9 12.5523 9 12V8H11.2374C12.1727 8 12.5961 6.83059 11.8776 6.23183L8.63965 3.53354Z"
        fill="black" class="gsac"></path>
    </svg></button></form>

<form class="gs1n">
  <p class="gs1o"><span class="gs2w">Hi there <img src="https://img.gs-chat.com/emoji/20/1f44b.png" alt="👋" title=":wave:" class="gs31"> Thanks for stopping by. If you need help with anything – just ask! <img
        src="https://img.gs-chat.com/emoji/20/1f4ac.png" alt="💬" title=":speech_balloon:" class="gs31"></span></p><input type="email" placeholder="Email Address" required="" class="gs1p"><textarea placeholder="Write a message…" required=""
    class="gs20 gs1p gs1q" style="height: 0px;"></textarea><button class="gs21 gs21_3 gs1r">Submit</button>
</form>

<form class="gs3k"><textarea placeholder="Write a message…" spellcheck="true" disabled="" rows="1" enterkeyhint="send" class="gs20 gs3l" style="height: 0px;"></textarea><input type="file" multiple="" class="gs3j"><button
    class="gs21 gs21_4 gs3m gs3p gs3n"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg">
      <rect width="16" height="16" fill="none"></rect>
      <path fill-rule="evenodd" clip-rule="evenodd"
        d="M8 3C7.44772 3 7 3.44772 7 4V7L4 7C3.44772 7 3 7.44771 3 8C3 8.55228 3.44772 9 4 9H7V12C7 12.5523 7.44772 13 8 13C8.55228 13 9 12.5523 9 12V9H12C12.5523 9 13 8.55228 13 8C13 7.44772 12.5523 7 12 7L9 7V4C9 3.44772 8.55228 3 8 3Z"
        fill="black" class="gsac"></path>
    </svg></button><button class="gs21 gs21_5 gs3m gs3q"><svg width="16" height="16" viewBox="0 0 16 16" fill="none" xmlns="http://www.w3.org/2000/svg">
      <path fill-rule="evenodd" clip-rule="evenodd"
        d="M8.63965 3.53354C8.2688 3.2245 7.73013 3.2245 7.35928 3.53354L4.12133 6.23183C3.40282 6.83059 3.82622 8 4.76151 8H7V12C7 12.5523 7.44718 13 8 13C8.55175 13 9 12.5523 9 12V8H11.2374C12.1727 8 12.5961 6.83059 11.8776 6.23183L8.63965 3.53354Z"
        fill="black" class="gsac"></path>
    </svg></button></form>

Text Content

REPORT STORE

 * Visit Corporate Site
 * Sign In

Menu
   


 * REPORT STORE

 * Sign in
 * Home
   
   
   * REPORTS
     
     View all Reports
     
     REPORTS BY SECTOR
     
      * Aerospace and Defense
      * Agriculture and Forestry
      * Apparel
      * Automotive
      * Business and Consumer Services
      * Chemicals
      * Construction
      * Consumer
      * COVID-19
      * Financial Services
      * Foodservice
      * Government and Non-Profit Organisations
      * Industrial Goods and Machinery
      * Medical Devices
      * Mining
      * Oil and Gas
      * Packaging
      * Pharmaceuticals
      * Power
      * Retail
      * Sport
      * Technology
      * Telecommunications
      * Transportation, Infrastructure and Logistics
      * Travel and Tourism
     
     REPORT TYPE
     
      * Company Profile
      * Track & Monitor
      * Sector Analysis
      * Product Insights
      * Analyst Opinions
      * Company Insights
      * Thematic Analysis
      * Case Studies
 * Visit Corporate Site

Back to reports
 * Home
 * Reports
 * Current: Pharmaceuticals

1958504 1 Themes


STATE OF THE BIOPHARMACEUTICAL INDUSTRY 2023

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$1950
Buy Report View Sample

Published: December 23, 2022 Report Code: GDHCHT367

Share
 * Share on Twitter
 * Share on LinkedIn
 * Share on Facebook
 * Share via Email
 * Copy Link

Report Overview
 * Report Overview
 * Key Players
 * Table of Contents
 * FAQs

Accessing in-depth insights from the ‘State of the Biopharmaceutical Industry’
report will help you –

 * Examine the current attitudes of business leaders towards the emerging trends
   impacting the biopharmaceutical industry in the next 12 months.
 * Understand the most impactful emerging technologies – Industry, Regulatory
   and Macroeconomic factors that are going to impact and dominate the industry
   throughout 2023.
 * Identify the most impactful anticipated regulatory approvals and drug
   launches in the industry in 2023, highlight top-selling drugs (2022 vs 2023),
   and overview the clinical trials landscape for 2023.
 * Uncover the healthcare industry professionals’ sentiment about the industry’s
   growth prospects during the next 12 months and how this sentiment changed
   over the past 3 years.

How is the ‘State of the Biopharmaceutical Industry’ report different from other
reports in the market?

 * It measures which themes are going to have the greatest positive or negative
   impact on the pharmaceutical industry in 2023.
 * It provides a qualitative analysis of the top regions (Europe, North America,
   and APAC).
 * It analyzes key emerging trends (regulatory and macroeconomic trends) as well
   as emerging technologies.
 * The State of the Biopharmaceutical Industry report highlights the planned
   clinical trials, projected clinical trails completions, top-selling drugs,
   and drug launches that are going to happen in 2023.
 * Understand other topics that GlobalData identified as important for you
   (Inflation Reduction Act, prospects of deflation, the rise of ESG, and
   reshoring of pharmaceutical manufacturing) and adjust your business
   development strategies.

 We recommend this valuable source of information to anyone involved in:

 * Pharmaceutical Companies
 * Biotech
 * CMOs, CMOs, and CDMOs
 * Consulting Companies
 * Technology Companies and Start-ups
 * Professional Services (e.g., Investment, Equity Companies, Banks)

To Get a Snapshot of the State of the Biopharmaceutical Industry
Report, Download a Free Report Sample


STATE OF THE BIOPHARMACEUTICAL INDUSTRY REPORT OVERVIEW

The pharmaceutical industry has long been labeled as recession-proof, as
medicines are essential products that cannot be completely replaced. However,
the looming global recession is likely to have implications on healthcare
budgets, forcing governments and regulators to put more stringent laws in place
around drug pricing and market access. At the same time, the pharmaceutical
industry will have to deal with increased drug development costs that will
affect their margins.

The state of the biopharmaceutical industry research report examines the
business environment and trends that are going to shape the biopharmaceutical
industry in 2023. The report highlights the most impactful emerging
technologies, industry, regulatory, and macroeconomic factors that are going to
impact and dominate the industry throughout 2023.


KEY FINDINGS OF THE BIOPHARMACEUTICAL INDUSTRY

In 2023, businesses will face turbulent times, and the pharmaceutical industry
is not an exception. Financial and costs pressures, as well as increasing
regulations and an uncertain economic outlook will be contributing to decreased
levels of optimism in growth prospects. To sustain growth, the pharmaceutical
industry will need to innovate.

Furthermore, to remain competitive, businesses need to ensure integration,
cost-effectiveness, efficiency, and customer excellence, as well as to attain
innovative solutions and investor support. Vertical integration, patent expiry
of biologics, mega M&As, and ESG factors are anticipated to have the greatest
positive impact on the pharmaceutical industry. In addition, big data and AI
will continue to dominate as transformational forces in the healthcare sector in
2023.


EMERGING INDUSTRY TRENDS IN THE BIOPHARMACEUTICAL INDUSTRY

The key emerging industry trends in the biopharmaceutical industry are genomics,
immuno-oncology drug development, personalized/precision medicine, real-world
evidence, remote patient monitoring, electronic health records, biosimilar
uptake, decentralized/virtual clinical trials, digital therapeutics, and patient
empowerment among others. Genomics is identified as the top emerging
pharmaceutical industry trend for 2023.

Biopharmaceutical Industry Analysis, by Emerging Trends, 2023 (%)

For more emerging trend insights in the biopharmaceutical industry, download a
free report sample


EMERGING TECHNOLOGIES IN THE BIOPHARMACEUTICAL INDUSTRY

The key emerging technologies impacting the biopharmaceutical industry are AI,
big data, cybersecurity, digital media, social media, virtual and augmented
reality, IoT, robotics, application programming interfaces, cloud computing, 3-D
printing, and blockchain among others. Across all geographies, AI, followed by
big data are expected to have the biggest impact on the pharmaceutical industry
in 2023.

Biopharmaceutical Industry, by Emerging Technologies, 2023 (%)

For more emerging technology insights in the biopharmaceutical industry,
download a free report sample


BIOPHARMACEUTICAL INDUSTRY VALUE CHAIN

The value chain of the biopharmaceutical industry includes supply chain, drug
development, end-user experience, physician-targeted sales and marketing, drug
discovery, manufacturing, and patient-targeted sales and marketing. Supply chain
and manufacturing will be impacted the most by inflation in 2023.


THERAPY AREAS IN THE BIOPHARMACEUTICAL INDUSTRY

The top therapy areas for planned clinical trials to be initiated in 2023 in the
biopharmaceutical industry are oncology, central nervous system, infectious
disease, cardiovascular, gastrointestinal, metabolic disorders, respiratory,
immunology, musculoskeletal disorders, and dermatology. Oncology trials will
outnumber CNS and infectious disease trials.

Biopharmaceutical Industry, by Therapy Areas (To be Initiated in 2023, %)

For more insights on the therapy areas in the biopharmaceutical industry,
download a free report sample


BIOPHARMACEUTICAL INDUSTRY – COMPETITIVE LANDSCAPE

Top industry sponsors for trials projected to be completed in 2023 are
AstraZeneca, Novartis, Johnson & Johnson (J&J), F Hoffman La Roche, Pfizer, Eli
Lily, Merck, Abbvie, and GSK among others. AstraZeneca, Novartis, and Johnson &
Johnson (J&J) will likely complete the most industry trials in 2023.

Biopharmaceutical Industry, by Industry Sponsors, 2023 (%)

For more industry sponsor insights in the biopharmaceutical industry, download a
free report sample


BIOPHARMACEUTICAL INDUSTRY REPORT OVERVIEW

Key Emerging Trends Genomics, Immuno-Oncology Drug Development,
Personalized/Precision Medicine, Real-World Evidence, Remote Patient Monitoring,
Electronic Health Records, Biosimilar Uptake, Decentralized/Virtual Clinical
Trials, Digital Therapeutics, and Patient Empowerment Key Emerging Technologies
AI, Big Data, Cybersecurity, Digital Media, Social Media, Virtual and Augmented
Reality, IoT, Robotics, Application Programming Interfaces, Cloud Computing, 3-D
Printing, and Blockchain Key Value Chain Supply Chain, Drug Development,
End-User Experience, Physician-Targeted Sales and Marketing, Drug Discovery,
Manufacturing, and Patient-Targeted Sales and Marketing Key Therapy Areas
Oncology, Central Nervous System, Infectious Disease, Cardiovascular,
Gastrointestinal, Metabolic Disorders, Respiratory, Immunology, Musculoskeletal
Disorders, and Dermatology Key Industry Sponsors AstraZeneca, Novartis, Johnson
& Johnson (J&J), F Hoffman La Roche, Pfizer, Eli Lily, Merck, Abbvie, and GSK

Biopharmaceutical Industry Therapy Areas Outlook (2023)

 * Oncology
 * Central Nervous System
 * Infectious Disease
 * Cardiovascular
 * Gastrointestinal
 * Metabolic Disorders
 * Respiratory
 * Immunology
 * Musculoskeletal Disorders
 * Dermatology


SCOPE

This report provides:



   

 * A snapshot of current attitudes of business leaders toward the emerging
   industry trends and how they are shaping the future of the healthcare
   industry

   

 * Overview of the hindrances and drivers that will affect the state of the
   biopharmaceutical industry

   

 * Emerging technologies that are expected to have the greatest impact on the
   biopharmaceutical industry in the next 12 months

   

 * Executives’ opinions on the growth prospects of the biopharmaceutical
   industry over the next 12 months

   

 * Key industry shake-ups and trends to watch that represent both challenges and
   opportunities to the industry

   




REASONS TO BUY

   

 * Stay up to date with the major emerging technologies and regulatory,
   macroeconomic, and industry trends that will impact the pharmaceutical
   industry in 2023.

   

 * Explore how the biopharmaceutical landscape has changed

   

 * Identify the most impactful anticipated regulatory approvals and drug
   launches in the industry in 2023

   

 * Gain insight into the regulatory and microeconomics trends that will have
   positive and negative effects on the biopharmaceutical industry

   

 * Identify emerging industry trends and innovations to gain a competitive
   advantage

   



AbbVie
Acceleron Pharma
Atara Biotherapeutics
Beta Pharma
BioMarin Pharmaceutical
BioNTech
Bio-Thera Solutions
Boehringer Ingelheim
Bristol-Myers Squibb
Catalent
Celerity Pharmaceuticals
Celltrion
Coherus BioSciences
CSL Behring
CStone Pharmaceuticals
CVS Health Corp
EirGenix
Eli Lilly
Exelead
Exscientia
Ferring Pharmaceuticals
Fuji Pharma
GSK
Immunocore
Insud Pharma
InventisBio
Johnson & Johnson
Johnson Matthey
Legend Biotech
Loxo Oncology
Medicaid Health Plans of America
Merck
Merck & Co
Metrics Contract Services
Midas Pharma
Mirati Therapeutics
National Institute for Health and Care Excellence
Nippon Kayaku
Novartis
Ono Pharmaceutical
Optum
Organon
OS Therapies
PTC Therapeutics
Regeneron Pharmaceuticals
Samsung Bioepis
Sandoz
Sarepta Therapeutics
Shanghai Junshi Bioscience
Sino Biopharmaceutical
Stada Arzneimittel
Stelis Biopharma
Sumitomo Dainippon Pharma Oncology
Teva Pharmaceutical Industries
TRACON Pharmaceuticals
UnitedHealth Group
Veranova
Xbrane Biopharma



TABLE OF CONTENTS

1. Executive Summary


2. Study Design


3. Emerging Industry Trends


4. Emerging Regulatory and Macroeconomic Trends


5. Emerging Technologies


6. Industry Growth Prospects


7. Watch Outs


8. Summary of Key Findings


9. Appendix 1


10. Appendix 2


11. Contact Us




FREQUENTLY ASKED QUESTIONS

 * What are the key emerging industry trends in the biopharmaceutical industry?
   
   The key emerging industry trends in the biopharmaceutical industry are
   genomics, immuno-oncology drug development, personalized/precision medicine,
   real-world evidence, remote patient monitoring, electronic health records,
   biosimilar uptake, decentralized/virtual clinical trials, digital
   therapeutics, and patient empowerment.
   
   

 * What are the key emerging technologies in the biopharmaceutical industry?
   
   The key emerging technologies in the biopharmaceutical industry are AI, big
   data, cybersecurity, digital media, social media, virtual and augmented
   reality, IoT, robotics, application programming interfaces, cloud computing,
   3-D printing, and blockchain.
   
   

 * What are the key biopharmaceutical industry value chains?
   
   The value chain of the biopharmaceutical industry includes supply chain, drug
   development, end-user experience, physician-targeted sales and marketing,
   drug discovery, manufacturing, and patient-targeted sales and marketing.
   
   

 * What are the key therapy areas in the biopharmaceutical industry?
   
   The key therapy areas in the biopharmaceutical industry are oncology, central
   nervous system, infectious disease, cardiovascular, gastrointestinal,
   metabolic disorders, respiratory, immunology, musculoskeletal disorders, and
   dermatology.
   
   

 * Who are the key industry sponsors in the biopharmaceutical industry?
   
   The key industry sponsors in the biopharmaceutical industry are AstraZeneca,
   Novartis, Johnson & Johnson (J&J), F Hoffman La Roche, Pfizer, Eli Lily,
   Merck, Abbvie, and GSK.
   
   

Currency USD
 * Currency Conversion is for Indicative purpose only. All orders are processed
   in US Dollars only.
 * USD - US Dollar
 * AUD — Australian Dollar
 * BRL — Brazilian Real
 * CNY — Yuan Renminbi
 * EUR — Euro
 * GBP — Pound Sterling
 * INR — Indian Rupee
 * JPY — Japanese Yen
 * ZAR — South African Rand

Single User
$1,950

Can be used by individual purchaser only

Most Popular
Multi-users
$2,925

Can be shared by unlimited users within one corporate location e.g. a regional
office

Enterprise
$3,900

Can be shared globally by unlimited users within the purchasing corporation e.g.
all employees of a single company

Buy Now Add to Basket

--------------------------------------------------------------------------------

UNDECIDED ABOUT PURCHASING THIS REPORT?

Enquire Before Buying Request a Free Sample

GET IN TOUCH TO FIND OUT ABOUT MULTI-PURCHASE DISCOUNTS



reportstore@globaldata.com
Tel +44 20 7947 2745



Every customer’s requirement is unique. With over 220,000 construction projects
tracked, we can create a tailored dataset for you based on the types of projects
you are looking for. Please get in touch with your specific requirements and we
can send you a quote.






SAMPLE REPORT

State of the Biopharmaceutical Industry 2023 was curated by the best experts in
the industry and we are confident about its unique quality. However, we want you
to make the most beneficial decision for your business, so we offer free sample
pages to help you:

 * Assess the relevance of the report
 * Evaluate the quality of the report
 * Justify the cost

Download your copy of the sample report and make an informed decision about
whether the full report will provide you with the insights and information you
need.

BELOW IS A SAMPLE REPORT TO UNDERSTAND WHAT YOU ARE BUYING

Click here to download sample
See what our customers are saying

GlobalData provides a great range of information and reports on various sectors
that is highly relevant, timely, easy to access and utilise.  The reports and
data dashboards help engagement with clients; they provide valuable industry and
market insights that can enrich client conversations and can help in the shaping
of value propositions. Moreover, using GlobalData products has helped increase
my knowledge of the finance sector, the players within it, and the general
threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and
not something I have seen anywhere else. They provided an insightful view of why
and which consumers take (or don’t) particular financial products. This can help
shape conversations with clients to ensure they make the right strategic
decisions for their business.

One of the challenges I have found is that data in the payments space is often
piecemeal. With GD all of the data I need is in one place, but it also comes
with additional market reports that provide useful extra context and
information. Having the ability to set-up alerts on relevant movements in the
industry, be it competitors or customers, and have them emailed directly to me,
ensures I get early sight of industry activity and don’t have to search for
news.



Senior Account Manager, TSYS

“The GlobalData platform is our go-to tool for intelligence services. GlobalData
provides an easy way to access comprehensive intelligence data around multiple
sectors, which essentially makes it a one-for-all intelligence platform, for
tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised
services, which benefits everyday use. The highly detailed project intelligence
and forecast reports can be utilised across multiple departments and workflow
scopes, from operational to strategic level, and often support strategic
decisions. GlobalData Analytics and visualisation solutions has contributed
positively when preparing management presentations and strategic papers.”



Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19
intelligence from GlobalData has helped us reach better decisions around
strategy. These two highlights have helped enormously to understand the
projections into the future concerning our business units, we also utilise the
project database to source new projects for Liebherr-Werk to use as an
additional source to pitch for new business.”



Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is
happening in the market, I like that you almost always have a link to the source
origin. We also use your market data in our Strategic Business Process to
support our business decisions. By having everything in one place on the
Intelligence Center it has saved me a lot of time versus looking on different
sources, the alert function also helps with this.



Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData
manages to provide that ‘difficult-to-get’ market data that others can’t, as
well as very diverse and complete consumer surveys.



Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to
the people. I find that the analysts and the account team have a high level of
customer focus and responsiveness and therefore I can always rely on. The
platform is more holistic than other providers. It is convenient and almost like
a one stop shop. The pricing suite is highly competitive and value for our
organisation.

I like reports that inform new segments such as the analysis on generation Z,
millennials, the impact of COVID 19 to our banking customers and their new
channel habits. Secondly the specialist insight on affluent sector significantly
increases our understanding about this group of customers. The combination of
those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the
intelligence center I can do that, effectively and efficiently. I can share
quickly key insights that answer and satisfy our country stakeholders by giving
them many quality studies and primary research about competitive landscape
beyond the outlook of our bank. It helps me be seen as an advisory partner and
that makes a big difference. A big benefit of our subscription is that no one
holds the whole data and because it allows so many people, so many different
parts of our organisation have access, it enables all teams to have the same
level of knowledge and decision support.



Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the
right consumer and market insights. I use Globaldata insights to understand the
changing market & consumer landscape and help create better taste & wellbeing
solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared
to your competitors. Globaldata not only has overall market sizes & consumer
insights on food & beverages but also provides insights at the ingredient &
flavour level. That is key for B2B companies like Givaudan. This way we
understand our customers’ business and also gain insight to our unique industry”



Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors
that is highly relevant, timely, easy to access and utilise.  The reports and
data dashboards help engagement with clients; they provide valuable industry and
market insights that can enrich client conversations and can help in the shaping
of value propositions. Moreover, using GlobalData products has helped increase
my knowledge of the finance sector, the players within it, and the general
threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and
not something I have seen anywhere else. They provided an insightful view of why
and which consumers take (or don’t) particular financial products. This can help
shape conversations with clients to ensure they make the right strategic
decisions for their business.

One of the challenges I have found is that data in the payments space is often
piecemeal. With GD all of the data I need is in one place, but it also comes
with additional market reports that provide useful extra context and
information. Having the ability to set-up alerts on relevant movements in the
industry, be it competitors or customers, and have them emailed directly to me,
ensures I get early sight of industry activity and don’t have to search for
news.



Senior Account Manager, TSYS

“The GlobalData platform is our go-to tool for intelligence services. GlobalData
provides an easy way to access comprehensive intelligence data around multiple
sectors, which essentially makes it a one-for-all intelligence platform, for
tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised
services, which benefits everyday use. The highly detailed project intelligence
and forecast reports can be utilised across multiple departments and workflow
scopes, from operational to strategic level, and often support strategic
decisions. GlobalData Analytics and visualisation solutions has contributed
positively when preparing management presentations and strategic papers.”



Business Intelligence & Marketing Manager, SAL Heavy Lift


RELATED REPORTS

View more Pharmaceuticals reports
Pharmaceuticals

Likelihood of Approval and Phase Transition Success Rate Model -…
$500 | February 2021
Pharmaceuticals
New

Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes in…
$995 | November 2023
Pharmaceuticals
New

Multiple Myeloma Epidemiology Analysis and Forecast to 2032
$3,995 | November 2023
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence
Center.

Subscribing to our intelligence platform means you can monitor developments at
State of the Biopharmaceutical Industry 2023 in real time.

 * Access a live State of the Biopharmaceutical Industry 2023 dashboard for 12
   months, with up-to-the-minute insights.
 * Fuel your decision making with real-time deal coverage and media activity.
 * Turn insights on financials, deals, products and pipelines into powerful
   agents of commercial advantage.

Tell me more

--------------------------------------------------------------------------------

 * Hot Topics
 * Terms & Conditions
 * Privacy Policy
 * Contact
 * Sitemap
 * Modern Slavery Statement

   --------------------------------------------------------------------------------

Top of page
© GlobalData Plc 2023 | Registered Office: John Carpenter House, John Carpenter
Street, London, EC4Y 0AN, UK | Registered in England No. 03925319
Themes
Thematic Analysis

Report Detail Page


SEARCH OUR DATABASE


Trending:
Ukraine Crisis Briefing Inflation COVID-19 Sustainability Tesla Netflix Vaccine
×
Can be used by individual purchaser only
Can be shared by unlimited users within one corporate location e.g. a regional
office
Can be shared globally by unlimited users within the purchasing corporation e.g.
all employees of a single company


PRIVACY PREFERENCE CENTER

When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer.
More information
Allow All


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.

View Vendor Details‎

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

View Vendor Details‎

FUNCTIONAL COOKIES

Functional Cookies

These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.

View Vendor Details‎

TARGETING COOKIES

Targeting Cookies

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

View Vendor Details‎
Back Button Back



Vendor Search Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

 * 
   
   View Cookies
   
    * Name
      cookie name

Confirm My Choices



WE VALUE YOUR PRIVACY

We may store and access personal data such as cookies, device identifiers or
other similar technologies on your device and process such data to enhance site
navigation, personalize ads and content when you visit our sites, measure ad and
content performance, gain audience insights, analyze our site traffic as well as
develop and improve our products and services. Further information on the
cookies we use and their purpose can be found on our website privacy policy
accessible here.

We use necessary cookies to make our site work. Necessary cookies enable core
functionality such as security, network management, and accessibility. You may
disable these by changing your browser settings, but this may affect how the
website functions. We'd also like to set optional cookies to help us improve our
website and help improve your experience whilst on our website.

By clicking ‘Accept All Cookies’ you agree to us enabling all optional cookies
for these purposes. Alternatively, you can set which optional cookies you wish
to enable (and update your preferences including withdrawing your consent) at
any time, by clicking ‘Cookie Settings’.

Accept All Cookies
Cookies Settings



Dismiss

GlobalData from GlobalData

Hi there Thanks for stopping by. If you need help with anything – just ask!


GoSquared Assistant
Chat with GlobalData

GoSquared Assistant

Hi there Thanks for stopping by. If you need help with anything – just ask!

Submit
GoSquared Assistant
Chat with GlobalData

GoSquared Assistant

Your conversation with GlobalData starts here
Today
Hi there Thanks for stopping by. If you need help with anything – just ask!
10:54 • GlobalData 

Unread messages
GoSquared Assistant

Drop files here to upload



4,308

Visitors

are online now

WiserNotify